EULAR Task Force Ongoing Initiatives

  • QoC001 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis, 2021-22
    D. van der Heijde/S- Ramiro

  • QoC002 - EULAR Points to Consider for the definition of clinical and imaging features suspicious for progression to psoriatic arthritis, 2021-22D
    McGonagle/J. Smolen

  • QoC003 - EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritides and a recent history of cancer, 2021-22 
    J.-E. Gottenberg

  • QoC004 - Development of EULAR/ACR Criteria for Disease Activity and Response in Giant Cell Arteritis
    Dejaco, Langford

  • QoC006 - Development and Validation of a EULAR disease activity score in Antiphospholipid syndrome
    M. Tektonidou

  • QoC007 - Recommendations for a core data set to support translational and observational research and clinical care in systemic lupus erythematosus
    M. Schneider

  • QoC008 - Update of the 2016 EULAR recommendations for the management of ANCA-associated vasculitis
    B. Hellmich

  • QoC009 - EULAR recommendations for the Management of Rheumatoid Arthritis: 2022 Update
    J. Smolen

  • QoC010 - Update of EULAR recommendations for the treatment of Systemic Sclerosis
    Y. Allanore, F. Del Galdo

  • CLI124 - EULAR points to consider for remote care in rheumatic and musculoskeletal diseases RMDs
    Christian Dejaco and Annette de Turah

  • CLI123 - Update of the EULAR 2020 provisional recommendations for the management of RMDs in the context of SARS-CoV-2

  • CLI121 - Classification Criteria for pediatric chronic recurrent multifocal osteomyelitis (CRMO) joint call 2019 (ACR/EULAR joint project)
    Seza Özen Yongdong Zhao

  • CLI119 - Joint EULAR/ERS diagnostic and therapeutic approach of interstitial lung disease in connective tissue diseases
    Anna-Maria Hoffmann-Vold

  • CLI118 - EULAR recommendations for screening and prophylaxis for opportunistic and chronic infectious diseases
    Kimme Hyrich

  • CLI117 - EULAR Classification criteria for haemochromatosis arthropathy
    Patrick Kiely

  • CLI116ACR - EULAR Classification Criteria for Calcium Pyrophosphate Depostion Disease (CPDD)
    Hyon Choi / Abhishek Abhishek

  • CLI114 - Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatology
    John Isaacs

  • CLI113 - Development And Validation of a EULAR disease activity score in adult onset Still’s Disease: the “DAVID” project
    Roberto Giacomelli

  • CLI112 - EULAR Recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases (including SLE and the antiphospholipid syndrome)
    Michael Nurmohamed / Maria Tektonidou

  • CLI108 - EULAR-ACR Classification Criteria for Antisynthetase Syndrome (CLASS)
    Aggarwal Rohit (ACR), Cavagna Lorenzo (EULAR)

  • CLI107 - ACR/EULAR Classification Criteria for Antiphospholipid Syndrome
    Doruk Erkan (ACR), Stephan Zuily (EULAR)

  • CLI100 - Development of EULAR points to consider/recommendations for including the perspective of young patients with inflammatory arthritis into patient-reported outcomes measures
    Paul Studenic

  • CLI098 - ACR-EULAR Criteria for Treatment Response for ANCA‐Associated Vasculitis
    Peter Merkel, Gunnar Tomasson

  • CLI088 - The Development of New Classification Criteria for Hand Osteoarthritis
    Margreet Kloppenburg

  • CLI083 - Development and validation of EULAR Systemic Sclerosis Impact of Disease (EULAR ScleroID) score
    Oliver Distler / T. Heiberg

  • IMG017 - EULAR Recommendations for the use of imaging in crystal-induced arthropathies in clinical practice
    Peter Mandl

  • IMG016 - EULAR recommendations for the use of imaging to guide interventional procedures in patients with Rheumatic and Musculoskeletal Diseases (RMD)
    Christian Dejaco

  • IMG015 - Guide/Recommendations for The Conduct, Content and Format of EULAR/PReS Paediatric Musculoskeletal Ultrasound Courses
    Silvia Magni-Manzoni

  • IMG013 - Imaging: EULAR Recommendations for the use of imaging in patient with mechanical back pain
    Gilles Fournier

  • CLI086 / IMG009 - Imaging: EULAR definition of Rheumatoid Arthritis Bone Erosion
    Frédérique Grandjbakhch, Georg Schett

  • CLI076 / IMG006 - Imaging: Development of a standardized training model for ultrasound-guided synovial biopsy’s in small and large joints
    Esperanza Naredo, Ingrid Möller ex Kelly

  • CLI050 /IMG003 - Imaging: EULAR recommendations /criteria for the appropriate use of musculoskeletal ultrasound in rheumatology clinical practice (Imaging)
    Maria-Antonietta d'Agostino

  • RES001 - EULAR Points to consider on risk stratification of populations for RA prevention studies, 2021-22
    A. van der Helm

  • EPI024 - EULAR Task Force to establish the evidence base and need for a EULAR Women’s Network for Clinical Academics (EULAR Task force for Gender Equity in Academic rheumatology (EULAR GEAR)
    Laura Coates

  • EPI023 - EULAR standardised operating procedures for implementing recommendations
    Estibaliz Loza

  • EPI020 - EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology
    D. Courvoisier, Axel Finckh, and Robert Landewé

  • EPI019 - 3rd RODs meeting Amsterdam
    Elena Nickiphorou, Loreto Carmona

  • EPI018 - EULAR Points to consider for lifestyle behaviour to prevent progression of Rheumatic and Musculoskeletal Diseases
    Suzan Verstappen

  • EPI010 - Tool Box
    Loreto Carmona (Sofia Ramiro is the new responsible since 2019)

  • EPI009 - Patient reported outcome initiative (PRO call)
    Deborah Symmons, Loreto Carmona

  • SCI020 - EULAR points to consider for minimal reporting requirements in synovial tissue clinical applications and research in rheumatology
    Andrew Filer, Aurélie Najm

  • SCI019 - EULAR recommendations/point to consider points to consider for the measurement and reporting of interferon activity in clinical research and future clinical application
    Edward Vital

  • SCI016 - EULAR recommendations for the use and interpretation of laboratory diagnostic tests for the management of systemic autoimmune rheumatic diseases
    Johan Rönnelid, Pier Luigi Meroni

  • SCI015 - Characterization of new tentative international reference reagents for clinical laboratory immunology/rheumatology analyses
    Johan Rönnelid

  • HPR055 - Update of the EULAR recommendations for non-pharmacological core management of hip and knee osteoarthritis
    N. Østerås

  • HPR054 - Translation of two upcoming recommendations with high relevance for HPRs into 6 languages and disseminate them in at least 8 countries:
    Translation & development of national quality improvement plans

    HPR: A.-K. Rausch

  • HPR053 - Online Course: Evidence Based Practice for HPR in rheumatology -
    from the database to EULAR recommendations. A journey through the body of evidence

    HPR: M. Testa, V. Ritschel

  • HPR052 - EULAR points to consider/recommendations for the management of fatigue in people with inflammatory rheumatic diseases
    E. Durres

  • HPR051 - EULAR Implementation of a mobile health app for the self-management of juvenile-onset rheumatic and musculoskeletal diseases during transitional care: a patient-centered approach. The Move-Up implementation project
    Fernando Estévez-López

  • HPR048 - Defining and optimising the use of qualitative research in the development of EULAR recommendations/points to consider
    Annette de Thurah

  • HPR047 - Increasing work participation across Europe, part II
    Ross Wilkie

  • HPR046 - EULAR recommendations/points to consider for the non-pharmacological management of connective tissue diseases with focus on systemic lupus erythematosus and systemic sclerosis
    Carina Boström

  • HPR044 - Increasing work participation across Europe
    Ross Wilkie

  • HPR043 - Implementation of Physical Activity into routine Clinical pracTice in Rheumatic Musculoskeletal Disease: The IMPACT-RMD study
    Georg Metsios

  • HPR042 - Implementation of EULAR Education for HPR in Eastern European countries
    Thea Vliet Vlieland

  • HPR041 - People with RMDs will act as multipliers to support others to stay in or return to paid and unpaid work
    Erika Mosor

  • HPR040 - Assessing the implementation of the EULAR recommendations for patient education for people with inflammatory arthritis across Europe
    Mwidimi Ndosi

  • EDU049 - School Fellows Classroom: EULAR standards for the training of European rheumatologists

  • PAF001 - Points to consider RMDs & Work – Policy recommendations for improved working conditions
    Suzanne Verstappen, Annelies Boonen

Related Information

Call for Task Force members

We look for experienced investigators in the mentioned fields of rheumatology. To apply as task force member, please send your one-page letter of interest to participate and a short CV to Simona Lupatin (

EULAR SOP for EULAR Recommendations/Points to Consider selection of task force members (PDF)

Application for Project Grants

EULAR welcomes project applications from rheumatologists across Europe designed for developing EULAR Recommendations, EULAR Criteria, EULAR Points to Consider, or similar projects.

See more

EULAR Recommendations

The EULAR Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations are developed by a Task Force of specialists in their field.

See more